Yiqun Li1, Jing Huang2, Chaojun Hu3, Jiaxin Zhou3, Dong Xu3, Yong Hou3, Chanyuan Wu3, Jiuliang Zhao3, Mengtao Li3, Xiaofeng Zeng3, Changzheng Liu4, Qian Wang5, Yan Zhao6. 1. Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China. 2. Department of Rheumatology, Central South University Xiangya Hospital, Changsha, China. 3. Department of Rheumatology, Peking Union Medical College Hospital, Peking Union Medical College & Chinese Academy of Medical Sciences, National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, Beijing, China. 4. NHC Key Laboratory of Systems Biology of Pathogens and Christophe Mérieux Laboratory, IPB, CAMS-Fondation Mérieux, Institute of Pathogen Biology (IPB), Chinese Academy of Medical Sciences (CAMS) & Peking Union Medical College, Beijing, China. 5. Department of Rheumatology, Peking Union Medical College Hospital, Peking Union Medical College & Chinese Academy of Medical Sciences, National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, Beijing, China. wangqian_pumch@126.com. 6. Department of Rheumatology, Peking Union Medical College Hospital, Peking Union Medical College & Chinese Academy of Medical Sciences, National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, Beijing, China. zhaoyan_pumch2002@aliyun.com.
Abstract
BACKGROUND: Systemic sclerosis (SSc) is an acquired autoimmune disorder characterized by excessive accumulation of collagen and progressive tissue fibrosis. Although interstitial lung disease (ILD) complicates the majority of SSc patients and is the leading cause of death, its pathogenesis remains largely unclear. In the current study, we aimed to evaluate the role of microRNAs in SSc-ILD. METHODS: miRNA expression patterns were assessed by miRNA array and real-time PCR from serum and PBMCs of SSc-ILD patients and healthy controls. Bleomycin-induced SSc-ILD mouse model was used to verify the miRNA expression in the lung tissue. The function of miRNAs in pulmonary fibroblasts was assessed using miRNA inhibitors, and mimics. RESULTS: miR-320a was significantly downregulated in both SSc-ILD patients and mouse models. The inhibition or overexpression of miR-320a in human pulmonary fibroblasts significantly affected the protein expression of type I collagen. Luciferase reporter assay, RT-PCR, and western blot analysis identified TGFBR2 and IGF1R as direct targets of miR-320a. Upon TGF-β stimulation, the expression of miR-320a and collagen genes were significantly upregulated. CONCLUSION: miR-320a, together with its target genes, TGFBR2 and IGF1R, constituted a complex regulatory network, and played an important role in the fibrotic process of SSc-ILD. Investigation of more detailed mechanisms of miR-320a-mediated regulation of collagen expression may provide new therapeutic strategies for SSc-ILD.
BACKGROUND: Systemic sclerosis (SSc) is an acquired autoimmune disorder characterized by excessive accumulation of collagen and progressive tissue fibrosis. Although interstitial lung disease (ILD) complicates the majority of SSc patients and is the leading cause of death, its pathogenesis remains largely unclear. In the current study, we aimed to evaluate the role of microRNAs in SSc-ILD. METHODS: miRNA expression patterns were assessed by miRNA array and real-time PCR from serum and PBMCs of SSc-ILD patients and healthy controls. Bleomycin-induced SSc-ILD mouse model was used to verify the miRNA expression in the lung tissue. The function of miRNAs in pulmonary fibroblasts was assessed using miRNA inhibitors, and mimics. RESULTS: miR-320a was significantly downregulated in both SSc-ILD patients and mouse models. The inhibition or overexpression of miR-320a in human pulmonary fibroblasts significantly affected the protein expression of type I collagen. Luciferase reporter assay, RT-PCR, and western blot analysis identified TGFBR2 and IGF1R as direct targets of miR-320a. Upon TGF-β stimulation, the expression of miR-320a and collagen genes were significantly upregulated. CONCLUSION: miR-320a, together with its target genes, TGFBR2 and IGF1R, constituted a complex regulatory network, and played an important role in the fibrotic process of SSc-ILD. Investigation of more detailed mechanisms of miR-320a-mediated regulation of collagen expression may provide new therapeutic strategies for SSc-ILD.
Authors: Robin Verjans; Tim Peters; Francisco Javier Beaumont; Rick van Leeuwen; Tessa van Herwaarden; Wouter Verhesen; Chantal Munts; Mitchell Bijnen; Michiel Henkens; Javier Diez; Leon J de Windt; Frans A van Nieuwenhoven; Marc van Bilsen; Marie José Goumans; Stephane Heymans; Arantxa González; Blanche Schroen Journal: Hypertension Date: 2017-12-18 Impact factor: 10.190
Authors: F Meng; Z Zhang; W Chen; G Huang; A He; C Hou; Y Long; Z Yang; Z Zhang; W Liao Journal: Osteoarthritis Cartilage Date: 2016-01-14 Impact factor: 6.576
Authors: Alexander N Garcia; Nancy G Casanova; Carrie L Kempf; Tadeo Bermudez; Daniel G Valera; Jin H Song; Xiaoguang Sun; Hua Cai; Liliana Moreno-Vinasco; Taylor Gregory; Radu C Oita; Vivian Reyes Hernon; Sara M Camp; Claude Rogers; Espoir M Kyubwa; Naresh Menon; James Axtelle; Jay Rappaport; Christian Bime; Saad Sammani; Anne E Cress; Joe G N Garcia Journal: Am J Respir Cell Mol Biol Date: 2022-05 Impact factor: 7.748
Authors: Ma'mon M Hatmal; Mohammad A I Al-Hatamleh; Amin N Olaimat; Walhan Alshaer; Hanan Hasan; Khaled A Albakri; Enas Alkhafaji; Nada N Issa; Murad A Al-Holy; Salim M Abderrahman; Atiyeh M Abdallah; Rohimah Mohamud Journal: Biomedicines Date: 2022-05-24